Deep search
Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent

News

Medicare, Ozempic and Wegovy and drugs for weight loss

Newsweek on MSN · 2d
Medicare update: Trump admin launching pilot program to cover Ozempic
Drugs known as GLP-1 receptor agonists were initially developed to treat Type 2 diabetes but have become a cultural phenomenon.
Gizmodo · 3d
Feds Launch Experiment to Have Medicare Cover GLP-1 Weight Loss Drugs
The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity medications.
The Independent on MSN · 3d
Medicare and Medicaid move toward covering Ozempic and other weight loss drugs
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the weight loss drugs, according to a new report.
BioSpace
5h
CMS Mulls About-Face in Coverage of GLP-1 Treatments for Obesity: Report
Earlier this year, the Centers for Medicare and Medicaid Services scrapped a previous proposal, from the Biden administration ...
2don MSN
A Medicare experiment could change who gets Ozempic
If a new experiment pans out, Medicaid and Medicare could begin covering the costly weight-loss drugs that price out many ...
3hon MSN
Nearly 17 Million Young Americans Could Benefit From Ozempic-like Drugs
Despite this, one in five young adults who meet the criteria for the drugs are uninsured and one-third denied having a routine place for healthcare.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results
Feedback
© 2025 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback
  • Your Privacy Choices
  • Consumer Health Privacy